Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Matinas BioPharma Hldgs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MTNB.
You can purchase shares of Matinas BioPharma Hldgs (AMEX:MTNB) through any online brokerage.
Other companies in Matinas BioPharma Hldgs’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Synaptogenix (NASDAQ:SNPX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Matinas BioPharma Hldgs has a consensus price target of $3.00.
The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $0.5401 last updated March 28, 2025 at 8:00 PM EDT.
There are no upcoming dividends for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Matinas BioPharma Hldgs.
Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.